Targeted treatment for sonic hedgehog-dependent medulloblastoma

od Kieran, Mark W.
Izdano 2014

Lessons learned from diffuse intrinsic pontine glioma: how a terrible disease forced us to think better

od Kieran, Mark W.
izdano v Neuro Oncol (2017)

The Integration of Biology Into the Treatment of Diffuse Intrinsic Pontine Glioma: A Review of the North American Clinical Trial Perspective

od Clymer, Jessica, Kieran, Mark W.
izdano v Front Oncol (2018)

The VEGF Pathway in Cancer and Disease: Responses, Resistance, and the Path Forward

od Kieran, Mark W., Kalluri, Raghu, Cho, Yoon-Jae
Izdano 2012

New Strategies in Pediatric Gliomas: Molecular Advances in Pediatric Low-Grade Gliomas as a Model

od Raabe, Eric, Kieran, Mark W., Cohen, Kenneth J.
izdano v Clin Cancer Res (2013)

Multidisciplinary pediatric brain tumor clinics: the key to successful treatment?

od Abdel-Baki, Mohamed S, Hanzlik, Emily, Kieran, Mark W
izdano v CNS Oncol (2015)

PPARs: A Double-Edged Sword in Cancer Therapy?

od Panigrahy, Dipak, Kaipainen, Arja, Kieran, Mark W., Huang, Sui
Izdano 2008

Future Clinical Trials in DIPG: Bringing Epigenetics to the Clinic

od Morales La Madrid, Andres, Hashizume, Rintaro, Kieran, Mark W.
izdano v Front Oncol (2015)

QOS-01 MULTIDISCIPLINARY PEDIATRIC BRAIN TUMOR CLINICS: THE KEY TO SUCCESSFUL TREATMENT?

od AbdelBaki, Mohamed S., Hanzlik, Emily, Dougherty, Mary, Kieran, Mark
izdano v Neuro Oncol (2016)

MBCL-02. CURRENT ISSUES IN THE MANAGEMENT OF DESMOPLASTIC NODULAR MEDULLOBLASTOMA IN YOUNG CHILDREN

od AbdelBaki, Mohamed, Boué, Daniel, Finlay, Jonathan, Kieran, Mark
izdano v Neuro Oncol (2018)

MB-66 PILOT STUDY OF A SURGERY AND CHEMOTHERAPY-ONLY APPROACH IN THE UPFRONT THERAPY OF CHLDREN WITH Wnt POSITIVE STANDARD RISK MEDULLOBLASTOMA

od Cohen, Kenneth, Bandopadhayay, Pratiti, London, Wendy, Chi, Susan, Kieran, Mark
izdano v Neuro Oncol (2016)

TB-03 IMMUNOPHENOTYPING OF PEDIATRIC BRAIN TUMORS: CORRELATING IMMUNE INFILTRATE WITH HISTOLOGY, MUTATIONAL LOAD, AND SURVIVAL

od Plant, Ashley, Koyama, Shohei, Dranoff, Glenn, Kieran, Mark, Ritz, Jerome
izdano v Neuro Oncol (2016)

The decision‐making process and criteria in selecting candidate drugs for progeria clinical trials

od Gordon, Leslie B, Kieran, Mark W, Kleinman, Monica E, Misteli, Tom
izdano v EMBO Mol Med (2016)

QOL-28. CUTANEOUS REACTIONS TO TARGETED THERAPIES IN CHILDREN WITH CNS TUMORS: A CROSS-SECTIONAL STUDY

od Zhong, Connie, Song, Hannah, Kieran, Mark, Chi, Susan, Wright, Karen, Huang, Jennifer
izdano v Neuro Oncol (2018)

Desmoplastic nodular medulloblastoma in young children: a management dilemma

od AbdelBaki, Mohamed S, Boué, Daniel R, Finlay, Jonathan L, Kieran, Mark W
izdano v Neuro Oncol (2018)

Role of Collagen Matrix in Tumor Angiogenesis and Glioblastoma Multiforme Progression

od Mammoto, Tadanori, Jiang, Amanda, Jiang, Elisabeth, Panigrahy, Dipak, Kieran, Mark W., Mammoto, Akiko
Izdano 2013

NS-26 THE ROLE OF SURGERY IN NON-NF-ASSOCIATED PEDIATRIC OPTIC PATHWAY GLIOMAS (OPG) - IS THERE A NEW PARADIGM?

od Lohkamp, Laura-Nanna, Manley, Peter, Kieran, Mark W., Ullrich, Nicole, Goumnerova, Liliana C.
izdano v Neuro Oncol (2016)

LGG-26. TYPE II BRAF INHIBITOR TAK-580 SHOWS PROMISE FOR UPCOMING CLINAL TRIAL AS EVIDENCED BY SINGLE PATIENT IND STUDY

od Wright, Karen D, Zimmerman, Mary Ann, Fine, Elizabeth, Aspri, Tristan, Kieran, Mark W, Chi, Susan
izdano v Neuro Oncol (2018)

Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity

od Eikesdal, Hans Petter, Sugimoto, Hikaru, Birrane, Gabriel, Maeshima, Yohei, Cooke, Vesselina G., Kieran, Mark, Kalluri, Raghu
Izdano 2008

Initial Cutaneous Manifestations of Hutchinson-Gilford Progeria Syndrome

od Rork, Jillian F., Huang, Jennifer T., Gordon, Leslie B., Kleinman, Monica, Kieran, Mark W., Liang, Marilyn G.
Izdano 2014